ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Final Issue of the Year

December 13, 1985

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Funding Opportunities: NIH Creates Awards For Clinical Research

March 27, 1998

$2-A-Pack Cigarette Tax A “Significant Deterrent,” NCAB Resolution Says

October 8, 1993